When clinical trials compete: Prioritising study recruitment

Journal of Medical Ethics

Volumn 43, Issue 12, 2017, Pages 803-809

  Gelinas, Luke ^a   Lynch, Holly Fernandez ^a   Bierer, Barbara E ^b   Cohen, I Glenn ^a  

^a HARVARD LAW SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clinical trials; Ethics; Philosophical Ethics; Research Ethics; Resource Allocation

Indexed keywords

CLINICAL TRIAL; COMPETITION; CONSENSUS; HUMAN; ORGANIZATIONAL POLICY; DECISION MAKING; ETHICS; HEALTH CARE PLANNING; MEDICAL RESEARCH; PATIENT SELECTION;

BIOMEDICAL RESEARCH; DECISION MAKING; HEALTH PRIORITIES; HUMANS; ORGANIZATIONAL POLICY; PATIENT SELECTION;

EID: 85011016333     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2016-103680     Document Type: Article

References (17)

1. Bennette CS, Ramsey SD, McDermott CL, et al. Predicting low accrual in the National Cancer Institute's Cooperative Group Clinical Trials. J Natl Cancer Inst 2015; 108: pii: djv324.
2. Ibrahim GM, Chung C, Bernstein M. Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials. J Neurooncol 2011; 104: 623-37.
3. Majersik J. Ethics and Bias of Enrolling in Competing Trials: A StrokeNet Survey and Status Update. http: //www. nihstrokenet. org/docs/default-source/ presentations/isc-nashville-2015/majersik--nashville15. pdf?sfvrsn=2. (accessed 8 Apr 2016).
4. Saver JL. Coping with an embarrassment of riches: how stroke centers may participate in multiple, concurrent clinical stroke trials. Stroke 1995; 26: 1289-92.
5. Roberts J, Silbergleit R. Competing Protocols for the, Same Patient Population: Who Should Choose? NIH Clinical Center Ethics Rounds, April 1, 2015. http: //videocast. nih. gov/Summary. asp?File=18926&bhcp=1. (accessed 13 Dec 2015).
6. Gordon EJ, Micetich KC. Competing clinical trials in the same institution: ethical issues in subject selection and informed consent. IRB 2002; 24: 1-7.
7. Denhoff ER, Milliren CE, de Ferranti SD, et al. Factors associated with clinical research recruitment in a pediatric academic medical center-a web-based survey. PLoS ONE 2015; 10: e0140768.
8. Daniels N. Fair process in patient selection for antiretroviral treatment in WHO's goal of 3 by 5. Lancet 2005; 366: 169-71.
9. Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet 2009; 373: 423-31.
10. Cohen IG. Rationing legal services. J Leg Anal 2013; 5: 221-307.
11. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2001; 283: 2701-11.
12. Chalmers I, Bracken MB, Djulbegovic B, et al. "How to increase value and reduce waste when research priorities are set. Lancet 2014; 383: 156-65.
13. Ioannidis JPA, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014; 383: 166-75.
14. Salman RA, Beller E, Kagan J, et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet 2014; 383: 176-85.
15. Halpern SD, Karlawish JH, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002; 288: 358-62.
16. Wertheimer A. Non-completion and informed consent. J Med Ethics 2014; 40: 127-30.
17. Appelabaum PS, Roth LH, Lidz CW, et al. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987; 17: 20-4.